We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Fujirebio Diagnostics Files 510(k) with FDA For Lumipulse G β-Amyloid Ratio

Product News   Dec 02, 2020

 
Fujirebio Diagnostics Files 510(k) with FDA For Lumipulse G β-Amyloid Ratio

Credit: Fujirebio Lumipulse

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

$10 Million Grant from Exact Sciences To Support Stand up to Cancer Initiative

Product News

Today Stand Up To Cancer announced a collaborative initiative aimed at improving colorectal cancer screening with a grant provided by Exact sciences.

READ MORE

EUROIMMUN launches SARS-CoV-2 Antigen Test

Product News

EUROIMMUN today announced the launch of the CE marked SARS-CoV-2 Antigen ELISA for specific determination of the SARS-CoV-2 protein.

READ MORE

Nēsos Unveils Wireless Earbud for the Treatment of Rheumatoid Arthritis

Product News

A new method for the treatment of rheumatoid arthritis using neuroplasticity-altering electrical fields is being developed by scientists, to regulate immune function.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE